U.S. Apollo, Booking Holdings, Portillos
Nov 6 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apollo, Booking Holdings and Portillos, on Wednesday.
HIGHLIGHTS
* Apollo APO.N: JP Morgan raises target price to $161 from $143 |
* Aris Water Solutions Inc ARIS.N: JP Morgan cuts to neutral from overweight |
* Booking Holdings Inc BKNG.O: Truist Securities raises target to $4,700 from $4,100 |
* Choice Hotels International Inc CHH.N: Jefferies cuts to hold from buy |
* Portillos Inc PTLO.O: Stifel cuts to hold from buy |
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* Abbvie ABBV.N: Guggenheim raises target price to $221 from $212 |
* Abbvie ABBV.N: HSBC raises target price to $230 from $215 |
* Aclaris Therapeutics Inc ACRS.O: Piper Sandler raises target price to $3 from $2 |
* Adapthealth Corp AHCO.O: Canaccord Genuity cuts target price to $13 from $14 |
* Adapthealth Corp AHCO.O: Jefferies cuts target price to $9 from $10.5 |
* Adapthealth Corp AHCO.O: UBS cuts target price to $12 from $13 |
* Addus Homecare Corp ADUS.O: RBC cuts target price to $136 from $141 |
* Addus Homecare Corp ADUS.O: Stephens raises target price to $145 from $143 |
* ADM ADM.N: BMO cuts target price to $55 from $60 |
* AGCO Corp AGCO.N: BMO cuts target price to $92 from $96 |
* AGCO Corp AGCO.N: JP Morgan cuts target price to $105 from $117 |
* AGCO Corporation AGCO.N: Truist Securities cuts target price to $110 from $127 |
* AGCO Corporation AGCO.N: Oppenheimer cuts target price to $111 from $131 |
* AIG AIG.N: Jefferies cuts target price to $86 from $88 |
* Alliant Energy Corp LNT.O: Barclays cuts target price to $59 from $61 |
* Alliant Energy Corporation LNT.O: Barclays cuts target price to $59 from $61 |
* Allstate Corp ALL.N: KBW raises target price to $225 from $222 |
* Alnylam Pharmaceuticals ALNY.O: Leerink Partners cuts target price to $178 from $180 |
* Alpha and Omega Semiconductor Ltd AOSL.O: Benchmark cuts target price to $40 |
* Alpha and Omega Semiconductor Ltd AOSL.O: Stifel cuts target price to $27 from $34 |
* Altria Group Inc MO.N: Barclays raises target price to $46 from $45 |
* American Homes 4 Rent AMH.N: KBW cuts target price to $38 from $39 |
* American International Group, Inc. AIG.N: Wells Fargo cuts target price to $76 from $77 |
* Anaptysbio Inc ANAB.O: H.C. Wainwright cuts target price to $52 from $55 |
* Anaptysbio Inc ANAB.O: Leerink Partners cuts target price to $45 from $47 |
* Apellis Pharmaceuticals Inc APLS.O: Oppenheimer cuts target price to $40 from $65 |
* Apellis Pharmaceuticals Inc APLS.O: Citigroup cuts target price to $51 from $63 |
* Apellis Pharmaceuticals Inc APLS.O: H.C. Wainwright cuts target price to $57 from $83 |
* Apellis Pharmaceuticals Inc APLS.O: Mizuho cuts target price to $30 from $38 |
* Apellis Pharmaceuticals Inc APLS.O: Piper Sandler cuts target price to $32 from $40 |
* Apellis Pharmaceuticals Inc APLS.O: RBC cuts target price to $24 from $25 |
* Apellis Pharmaceuticals Inc APLS.O: Scotiabank cuts target price to $30 from $35 |
* Apellis Pharmaceuticals Inc APLS.O: TD Cowen cuts target price to $60 from $95 |
* Apellis Pharmaceuticals Inc APLS.O: Wells Fargo cuts target price to $30 from $43 |
* Apollo APO.N: Barclays raises target price to $174 from $148 |
* Apollo APO.N: BMO raises target price to $157 from $138 |
* Apollo APO.N: Citigroup raises target price to $170 from $162 |
* Apollo APO.N: JP Morgan raises target price to $161 from $143 |
* Apollo APO.N: KBW raises target price to $168 from $159 |
* Apollo APO.N: TD Cowen raises target price to $178 from $165 |
* Apollo Global Management APO.N: Deutsche Bank raises target price to $155 from $141 |
* Apollo Global Management APO.N: Wells Fargo raises target price to $164 from $149 |
* Arcellx Inc ACLX.O: Baird raises target price to $106 from $77 |
* Arcellx Inc ACLX.O: H.C. Wainwright raises target price to $95 from $80 |
* Arcellx Inc ACLX.O: Morgan Stanley raises target price to $106 from $81 |
* Aris Water Solutions Inc ARIS.N: JP Morgan cuts to neutral from overweight |
* Aris Water Solutions Inc ARIS.N: JP Morgan raises target price to $22 from $19 |
* Aris Water Solutions Inc ARIS.N: Stifel raises target price to $26 from $20 |
* Aris Water Solutions Inc ARIS.N: Wells Fargo raises target price to $21 from $17 |
* Aspen Technology Inc AZPN.O: Piper Sandler raises target price to $240 from $217 |
* Avalonbay Communities Inc AVB.N: RBC cuts target price to $233 from $234 |
* Avalonbay Communities Inc AVB.N: Wedbush raises target price to $233 from $225 |
* B&G Foods Inc BGS.N: RBC cuts target price to $9 from $10 |
* B&G Foods Inc BGS.N: TD Cowen cuts target price to $7.50 from $8 |
* Bath & Body Works Inc BBWI.N: Wells Fargo cuts target price to $32 from $35 |
* Beam Therapeutics Inc BEAM.O: Leerink Partners raises target price to $39 from $27 |
* Beam Therapeutics Inc BEAM.O: Leerink Partners raises to outperform from market perform |
* Beam Therapeutics Inc BEAM.O: RBC cuts target price to $24 from $27 |
* Bellring Brands Inc BRBR.N: Barclays raises target price to $74 from $68 |
* Bioventus Inc BVS.O: Canaccord Genuity raises target price to $15 from $12 |
* Black Diamond Therapeutics Inc BDTX.O: Stifel cuts target price to $16 from $18 |
* Booking Holdings BKNG.O: Truist Securities raises target price to $4,700 from $4,100 |
* Bowhead Specialty Holdings Inc BOW.N: RBC raises target price to $35 from $32 |
* Bowhead Specialty Holdings Inc. BOW.N: Morgan Stanley raises target price to $31 from $30 |
* BRC Inc BRCC.N: Truist Securities cuts target price to $4 from $5 |
* Broadridge Financial Solutions Inc BR.N: D.A. Davidson raises target to $210 from $205 |
* Broadridge Financial Solutions Inc BR.N: JP Morgan raises target price to $231 from $225 |
* Broadridge Financial Solutions Inc BR.N: Morgan Stanley raises PT to $207 from $200 |
* Broadridge Financial Solutions Inc BR.N: Raymond James raises target to $235 from $230 |
* Brown-Forman Corp BFb.N: TD Cowen cuts target price to $48 from $50 |
* Brown-Forman Corp BFb.N: TD Cowen cuts to hold from buy |
* Bruker Corp BRKR.O: Barclays cuts target price to $69 from $75 |
* Bruker Corp BRKR.O: Citigroup cuts target price to $75 from $80 |
* Bruker Corp BRKR.O: JP Morgan cuts target price to $80 from $90 |
* Bruker Corp BRKR.O: Stifel cuts target price to $70 from $77 |
* Bruker Corp BRKR.O: Wells Fargo cuts target price to $75 from $78 |
* Builders Firstsource Inc BLDR.N: RBC raises target price to $187 from $178 |
* BWX Technologies BWXT.N: Deutsche Bank raises target price to $130 from $129 |
* Camden Property Trust CPT.N: Wedbush cuts target price to $132 from $137 |
* Camping World Holdings Inc CWH.N: JP Morgan cuts target price to $23 from $24 |
* Caretrust REIT Inc CTRE.N: Jefferies raises target price to $36 from $35 |
* Casey'S General Stores CASY.O: Deutsche Bank raises target price to $454 from $451 |
* Castle Biosciences Inc CSTL.O: Scotiabank raises target price to $44 from $37 |
* CBOE Global Markets Inc CBOE.Z: Morgan Stanley cuts to underweight from equal-weight |
* Celanese Corp CE.N: Baird cuts target price to $110 from $150 |
* Celanese Corp CE.N: Barclays cuts target price to $101 from $151 |
* Celanese Corp CE.N: Deutsche Bank cuts target price to $110 from $135 |
* Celanese Corp CE.N: Deutsche Bank raises to buy from hold |
* Celanese Corp CE.N: JP Morgan cuts target price to $92 from $130 |
* Celanese Corp CE.N: Morgan Stanley cuts target price to $100.00 from $140.00 |
* Century Therapeutics Inc IPSC.O: H.C. Wainwright cuts target price to $5 from $9 |
* Chemours CC.N: RBC cuts target price to $25 from $28 |
* Choice Hotels International Inc CHH.N: Jefferies cuts to hold from buy |
* Clorox CLX.N: TD Cowen raises target price to $170 from $155 |
* Clorox CLX.N: TD Cowen raises to hold from sell |
* Constellation Energy Corp CEG.O: Jefferies cuts target price to $234 from $256 |
* Corebridge Financial Inc CRBG.N: RBC raises target price to $35 from $32 |
* Coupang Inc CPNG.N: Mizuho raises target price to $25 from $23 |
* Crescent Energy Co CRGY.N: Truist Securities raises target price to $16 from $15 |
* Cricut Inc CRCT.O: Morgan Stanley cuts target price to $3.90 from $4.20 |
* Cummins CMI.N: Jefferies raises target price to $410 from $385 |
* Cummins CMI.N: JP Morgan raises target price to $355 from $340 |
* Cummins CMI.N: Truist Securities cuts target price to $369 from $371 |
* CVR Energy Inc CVI.N: Mizuho cuts target price to $18 from $26 |
* Davita Inc DVA.N: Truist Securities cuts target price to $170 from $175 |
* Diamondback Energy Inc FANG.O: JP Morgan cuts target price to $191 from $205 |
* Digitalbridge Group Inc DBRG.N: KBW cuts target price to $14 from $17.75 |
* Digitalbridge Group Inc DBRG.N: KBW cuts to market perform from outperform |
* Distribution Solutions Group DSGR.O: Barrington Research raises PT to $44 from $43 |
* Dupont DD.N: Barclays raises target price to $85 from $84 |
* Dupont De Nemours Inc DD.N: Wells Fargo raises target price to $107 from $105 |
* Eastman Chemical Co EMN.N: RBC cuts target price to $105 from $107 |
* Editas Medicine Inc EDIT.O: Barclays cuts target price to $5 from $7 |
* Emerson EMR.N: Barclays raises target price to $116 from $103 |
* Emerson EMR.N: Deutsche Bank raises target price to $140 from $136 |
* Emerson EMR.N: Mizuho raises target price to $140 from $130 |
* Emerson EMR.N: RBC cuts target price to $138 from $139 |
* Emerson EMR.N: Wolfe Research raises target price to $134 from $124 |
* Emerson Electric EMR.N: Deutsche Bank raises target price to $140 from $136 |
* Emerson Electric Co EMR.N: Wells Fargo raises target price to $135 from $128 |
* Entegris Inc ENTG.O: Citigroup cuts target price to $123 from $130 |
* Entrada Therapeutics TRDA.O: H.C. Wainwright raises target price to $20 from $18 |
* Entrada Therapeutics, Inc. TRDA.O: Oppenheimer raises target price to $28 from $25 |
* Essex Property Trust Inc ESS.N: Wedbush raises target price to $308 from $301 |
* Eversource Energy ES.N: BMO cuts target price to $71 from $75 |
* Eversource Energy ES.N: UBS cuts target price to $78 from $83 |
* Exact Sciences Corp EXAS.O: BTIG cuts target price to $65 from $82 |
* Exact Sciences Corp EXAS.O: Canaccord Genuity cuts target price to $75 from $95 |
* Exact Sciences Corp EXAS.O: Citigroup cuts target price to $75 from $80 |
* Exact Sciences Corp EXAS.O: Craig-Hallum cuts target price to $65 from $82 |
* Exact Sciences Corp EXAS.O: Jefferies raises target price to $85 from $84 |
* Exact Sciences Corp EXAS.O: Leerink Partners cuts target price to $70 from $100 |
* Exact Sciences Corp EXAS.O: Stifel cuts target price to $67 from $82 |
* Exact Sciences Corp EXAS.O: TD Cowen cuts target price to $82 from $90 |
* Exact Sciences Corporation EXAS.O: Craig-Hallum cuts target price to $65 from $82 |
* Expeditors International of Washington EXPD.N: TD Cowen raises PT to $108 from $106 |
* Expeditors International of Washington Inc EXPD.N: Barclays raises target price to $110 from $105 |
* Expeditors International of Washington Inc EXPD.N: UBS cuts target price to $130 from $137 |
* Ferrari RACE.N: UBS raises target price to $513 from $478 |
* Fis FIS.N: Stephens raises target price to $100 from $98 |
* Flushing Financial Corp FFIC.O: D.A. Davidson raises target price by $2 to $16 |
* Freshpet Inc FRPT.O: Stephens raises target price to $180 from $160 |
* Freshpet Inc FRPT.O: Stifel raises target price to $165 from $155 |
* Gartner IT.N: Barclays raises target price to $525 from $470 |
* Gartner IT.N: BMO raises target price to $540 from $537 |
* Gartner IT.N: Deutsche Bank raises target price to $531 from $529 |
* Gartner IT.N: Jefferies raises target price to $525 from $505 |
* Gartner IT.N: Morgan Stanley raises target price to $560.00 from $528.00 |
* Gartner IT.N: Wells Fargo raises target price to $470 from $460 |
* Gartner Inc IT.N: UBS raises target price to $592 from $580 |
* Generac Holdings Inc GNRC.N: Wells Fargo raises target price to $175 from $156 |
* Globalfoundries GFS.O: Deutsche Bank cuts target price to $50 from $55 |
* Globalfoundries Inc GFS.O: Citigroup cuts target price to $40 from $45 |
* Globalfoundries Inc GFS.O: Morgan Stanley cuts target price to $40.00 from $43.00 |
* Globalfoundries Inc GFS.O: Susquehanna cuts target price to $48 from $50 |
* Globalfoundries Inc GFS.O: Wedbush cuts target price to $60 from $65 |
* Globus Medical Inc GMED.N: Canaccord Genuity raises target price to $85 from $79 |
* Globus Medical Inc GMED.N: Jefferies raises target price to $100 from $85 |
* Globus Medical Inc GMED.N: RBC raises target price to $92 from $80 |
* Globus Medical Inc GMED.N: Stifel raises target price to $92 from $80 |
* Globus Medical Inc GMED.N: Truist Securities raises target price to $85 from $79 |
* Globus Medical Inc GMED.N: Wells Fargo raises target price to $88 from $78 |
* Goodyear Tire & Rubber Co GT.O: JP Morgan raises target price to $18 from $17 |
* Grocery Outlet Holding Corp GO.O: Craig-Hallum cuts target price to $17 from $20 |
* Grocery Outlet Holding Corp GO.O: Craig-Hallum cuts target price to $17 from $20 |
* Grocery Outlet Holding Corp GO.O: Deutsche Bank cuts target price to $26 from $29 |
* Grocery Outlet Holding Corp GO.O: Morgan Stanley cuts target price to $13 from $23 |
* Grocery Outlet Holding Corp GO.O: Roth MKM cuts target price to $16 from $20 |
* Grocery Outlet Holding Corp GO.O: TD Cowen cuts to hold from buy; cuts PT to $16 from $25 |
* Grocery Outlet Holding Corp GO.O: Telsey Advisory Group cuts PT to $18 from $19 |
* Grocery Outlet Holding Corp GO.O: UBS cuts target price to $16 from $21 |
* Grocery Outlet Holding Corp GO.O: Wells Fargo cuts target price to $23 from $26 |
* GXO Logistics Inc GXO.N: Citigroup raises target price to $72 from $68 |
* GXO Logistics Inc GXO.N: TD Cowen raises target price to $83 from $82 |
* Gxo Logistics Inc GXO.N: UBS raises target price to $72 from $66 |
* GXO Logistics Inc GXO.N: Wells Fargo raises target price to $65 from $58 |
* HCA Healthcare Inc HCA.N: Wells Fargo raises target price to $400 from $395 |
* Highpeak Energy Inc HPK.O: Gerdes Energy Research cuts target price by $1 to $11 |
* Hillman Solutions Corp HLMN.O: Barclays raises target price to $12 from $10 |
* Hims & Hers HIMS.N: Deutsche Bank raises target price to $27 from $23 |
* Hims & Hers Health Inc HIMS.N: Truist Securities raises target price to $24 from $23 |
* Huntsman Corporation HUN.N: Wells Fargo cuts target price to $25 from $26 |
* Ingredion Inc INGR.N: Barclays raises target price to $168 from $145 |
* Ingredion Inc INGR.N: BMO raises target price to $147 from $128 |
* Ingredion Incorporated INGR.N: Oppenheimer raises target price to $178 from $147 |
* Inozyme pharma Inc INZY.O: Jefferies cuts target price to $15 from $17 |
* Inspire Medical Systems Inc INSP.N: Truist Securities raises PT to $250 from $240 |
* Integra Lifesciences Holdings IART.O: Truist Securities raises PT to $26 from $21 |
* Intellia Therapeutics Inc NTLA.O: Leerink Partners cuts target price to $51 from $60 |
* International Flavors & Fragrances Inc IFF.N: UBS raises target price to $111 from $108 |
* Invitation Homes Inc INVH.N: KBW cuts target price to $35 from $37 |
* Itron Inc ITRI.O: Guggenheim raises target price to $135 from $128 |
* J&J JNJ.N: Guggenheim raises target price to $162 from $156 |
* Jeld-Wen Holding Inc JELD.N: Barclays cuts target price to $10 from $13 |
* Jeld-Wen Holding Inc JELD.N: RBC cuts target price to $9 from $13 |
* Jeld-Wen Holding Inc JELD.N: Truist Securities cuts target price to $11 from $15 |
* Jeld-Wen Holding Inc JELD.N: UBS cuts target price to $15 from $19 |
* Jeld-Wen Holding Inc JELD.N: Barclays cuts target price to $10 from $13 |
* Kymera Therapeutics Inc KYMR.O: Morgan Stanley raises target price to $49 from $45 |
* Leidos LDOS.N: JP Morgan raises target price to $205 from $185 |
* Lindblad Expeditions Holdings Inc LIND.O: Craig-Hallum raises target to $16 from $12 |
* Lindblad Expeditions Holdings Inc LIND.O: Stifel raises target price to $18 from $15 |
* Lions Gate Entertainment Corp LGFa.N: Benchmark cuts target price to $13 from $15 |
* Lions Gate Entertainment Corp LGFb.N: Morgan Stanley cuts target price to $9 from $10 |
* Lionsgate Studios Corp LION.O: Morgan Stanley cuts target price to $8.00 from $9.00 |
* Lowe's Companies Inc LOW.N: Wells Fargo raises target price to $295 from $280 |
* LP Building Solutions LPX.N: RBC raises target price to $125 from $119 |
* LP Building Solutions LPX.N: TD Cowen raises target price to $123 from $115 |
* LP Building Solutions LPX.N: Truist Securities raises target price to $117 from $113 |
* LTC Properties Inc LTC.N: Jefferies raises target price to $35 from $33 |
* Lumen Technologies LUMN.N: TD Cowen cuts target price to $6 from $7 |
* Macrogenics Inc MGNX.O: BMO raises target price to $6 from $5 |
* Maplebear Inc CART.O: Oppenheimer raises target price to $55 from $48 |
* Marathon Petroleum Corp MPC.N: TD Cowen cuts target price to $170 from $174 |
* Marqeta Inc MQ.O: Citigroup cuts target price to $7 from $8 |
* Masimo Corp MASI.O: Jefferies raises target price to $145 from $125 |
* Masimo Corp MASI.O: Piper Sandler raises target price to $180 from $165 |
* Masimo Corporation MASI.O: Wells Fargo raises target price to $171 from $160 |
* Merck & Co Inc MRK.N: Guggenheim cuts target price to $130 from $137 |
* Mercury Systems Inc MRCY.O: Truist Securities raises target price to $35 from $31 |
* Meritage Homes Corp MTH.N: JP Morgan raises target price to $220 from $210 |
* Mgic Investment Corp MTG.N: RBC cuts target price to $27 from $28 |
* MGP Ingredients Inc MGPI.O: TD Cowen cuts target price to $50 from $66 |
* MGP Ingredients Inc MGPI.O: TD Cowen cuts to hold from buy |
* Microchip Technology MCHP.O: Citigroup cuts target price to $82 from $92 |
* Microchip Technology MCHP.O: Jefferies cuts target price to $90 from $100 |
* Microchip Technology MCHP.O: JP Morgan cuts target price to $90 from $100 |
* Microchip Technology MCHP.O: Mizuho cuts target price to $85 from $95 |
* Microchip Technology MCHP.O: Needham cuts target price to $85 from $96 |
* Microchip Technology MCHP.O: Piper Sandler cuts target price to $85 from $100 |
* Microchip Technology MCHP.O: Stifel cuts target price to $90 from $98 |
* Microchip Technology MCHP.O: Susquehanna cuts target price to $90 from $95 |
* Microchip Technology MCHP.O: TD Cowen cuts target price to $70 from $80 |
* Microchip Technology MCHP.O: Truist Securities cuts target price to $71 from $80 |
* Mid-America Apartment Communities Inc MAA.N: Wedbush cuts PT to $180 from $182 |
* Multiplan Corp MPLN.N: Piper Sandler cuts target price to $10 from $40 |
* Myers Industries Inc MYE.N: KeyBanc cuts to sector weight from overweight |
* Offerpad Solutions Inc OPAD.N: KBW cuts target price to $3.15 from $3.75 |
* Oge Energy Corp OGE.N: Wells Fargo raises target price to $43 from $42 |
* Omega Healthcare Investors Inc OHI.N: Jefferies raises target price to $40 from $36 |
* One Gas Inc OGS.N: Wells Fargo cuts target price to $81 from $82 |
* Otter Tail Corp OTTR.O: Siebert Williams raises target price to $81 from $80 |
* Pacs Group Inc PACS.N: JP Morgan resumes coverage with overweight rating; PT $40 |
* Payoneer Global Inc PAYO.O: Benchmark raises target price to $12 from $10 |
* Payoneer Global Inc PAYO.O: KBW raises target price to $12 from $9 |
* Payoneer Global Inc PAYO.O: Needham raises target price to $14 from $10 |
* Portillos Inc PTLO.O: Piper Sandler raises target price to $15 from $13 |
* Portillos Inc PTLO.O: Stifel cuts to hold from buy |
* Portillos Inc PTLO.O: UBS raises target price to $14 from $13 |
* Premier Inc PINC.O: Barclays raises target price to $24 from $20 |
* Premier Inc PINC.O: Canaccord Genuity raises target price to $21 from $19 |
* Public Service Enterprise Group Inc PEG.N: Mizuho cuts target price to $90 from $97 |
* Qualys Inc QLYS.O: Canaccord Genuity raises target price to $170 from $160 |
* Qualys Inc QLYS.O: Jefferies raises target price to $155 from $135 |
* Qualys Inc QLYS.O: JP Morgan raises target price to $126 from $125 |
* Qualys Inc QLYS.O: Morgan Stanley raises target price to $126.00 from $123.00 |
* Qualys Inc QLYS.O: Needham assumes coverage with hold rating |
* Qualys Inc QLYS.O: Northland Capital raises target price to $150 from $140 |
* Qualys Inc QLYS.O: RBC raises target price to $162 from $150 |
* Qualys Inc QLYS.O: TD Cowen raises target price to $150 from $130 |
* Qualys Inc QLYS.O: Truist Securities raises target price to $145 from $120 |
* Qualys Inc QLYS.O: UBS raises target price to $160 from $140 |
* Qualys Inc QLYS.O: Wedbush raises target price to $175 from $160 |
* Rambus Inc RMBS.O: Wells Fargo initiates coverage with overweight rating; PT $62 |
* Realty Income Corp O.N: RBC cuts target price to $63 from $67 |
* Revolve Group Inc RVLV.N: BTIG raises target price to $35 from $30 |
* Revolve Group Inc RVLV.N: Jefferies raises target price to $25 from $21 |
* Revolve Group Inc RVLV.N: Morgan Stanley raises target price to $28.00 from $26.00 |
* Revolve Group Inc RVLV.N: Roth MKM raises target price to $35 from $29 |
* Revolve Group Inc RVLV.N: Stifel raises target price to $35 from $24 |
* Revolve Group Inc RVLV.N: TD Cowen raises target price to $34 from $28 |
* Revolve Group Inc RVLV.N: UBS raises target price to $30 from $25 |
* Rhythm Pharmaceuticals Inc RYTM.O: Canaccord Genuity raises target to $80 from $77 |
* Rhythm Pharmaceuticals Inc RYTM.O: Morgan Stanley raises PT to $72.00 from $55.00 |
* Rhythm Pharmaceuticals Inc RYTM.O: Needham raises target price to $64 from $55 |
* Rhythm Pharmaceuticals Inc RYTM.O: TD Cowen raises target price to $65 from $55 |
* Rivian RIVN.O: Guggenheim cuts target price to $18 from $21 |
* Rocket Lab USA Inc RKLB.O: Citigroup raises target price to $13 from $7 |
* Sabra Health Care REIT Inc SBRA.O: Jefferies raises target price to $21 from $20 |
* SBA Communications Corp SBAC.O: RBC raises target price to $255 from $245 |
* Sensata Technologies Holding Plc ST.N: UBS cuts target price to $39 from $44 |
* Silicon Labs SLAB.O: Barclays cuts target price to $75 from $120 |
* Solaris Energy Infrastructure Inc SEI.N: Stifel raises target price to $23 from $15 |
* Sotera Health Co SHC.O: Barclays raises target price to $18 from $17 |
* Sotera Health Co SHC.O: Citigroup raises target price to $20 from $18 |
* Sotera Health Co SHC.O: Jefferies raises target price to $18 from $16.5 |
* Sunopta Inc STKL.O: Mizuho raises target price to $10 from $9 |
* Sunopta Inc STKL.O: Stephens raises target price to $10 from $9 |
* Super Micro Computer Inc SMCI.O: Barclays cuts target price to $25 from $42 |
* Super Micro Computer Inc SMCI.O: JP Morgan cuts target price to $23 from $50 |
* Super Micro Computer Inc SMCI.O: JP Morgan cuts to underweight from neutral |
* Super Micro Computer Inc SMCI.O: Wedbush cuts target price to $24 from $32 |
* Syndax Pharmaceuticals Inc SNDX.O: H.C. Wainwright raises target price to $47 from $45 |
* Tango Therapeutics Inc TNGX.O: Piper Sandler cuts target price to $15 from $18 |
* Targa Resources Corp TRGP.N: Raymond James raises target price to $200 from $185 |
* Targa Resources Corp TRGP.N: Stifel raises target price to $190 from $151 |
* Targa Resources Corp TRGP.N: Wells Fargo raises target price to $190 from $153 |
* Target Corp TGT.N: TD Cowen cuts target price to $165 from $180 |
* Tempus Ai Inc TEM.O: JP Morgan raises target price to $50 from $47 |
* Tempus Ai Inc TEM.O: Morgan Stanley raises target price to $50.00 from $46.00 |
* Tenet Healthcare Corporation THC.N: Wells Fargo raises target price to $205 from $195 |
* The Gap Inc GAP.N: Wells Fargo cuts target price to $28 from $32 |
* The Home Depot Inc HD.N: Wells Fargo raises target price to $430 from $400 |
* Timken Company TKR.N: Oppenheimer cuts target price to $97 from $102 |
* Timken Co TKR.N: D.A. Davidson cuts target price to $99 from $103 |
* Timken Co TKR.N: Jefferies cuts target price to $80 from $85 |
* Timken Co TKR.N: KeyBanc cuts target price to $90 from $104 |
* Transdigm Group Inc TDG.N: Citigroup cuts target price to $1563 from $1648 |
* Treace Medical Concepts Inc TMCI.O: Stifel raises target price to $8 from $7 |
* Treace Medical Concepts Inc TMCI.O: Truist Securities raises target price to $7 from $6 |
* Trulieve Cannabis Corp TRUL.CD: Cormark Securities cuts to market perform from buy |
* Uber UBER.N: D.A. Davidson raises target price to $84 from $82 |
* UDR Inc UDR.N: Wedbush raises target price to $50 from $49 |
* Ul Solutions Inc ULS.N: UBS raises target price to $54 from $52 |
* Ul Solutions Inc ULS.N: Wells Fargo raises target price to $62 from $56 |
* Ultragenyx Pharmaceutical Inc RARE.O: Canaccord Genuity raises target to $121 from $109 |
* Ultragenyx Pharmaceutical Inc RARE.O: H.C. Wainwright raises target price to $95 from $82 |
* Ultragenyx Pharmaceutical Inc RARE.O: Jefferies cuts target price to $124 from $129 |
* Ultragenyx Pharmaceutical Inc RARE.O: Morgan Stanley cuts target price to $64 from $67 |
* Ultragenyx Pharmaceutical Inc RARE.O: Wedbush raises target price to $48 from $47 |
* Universal Health Services Inc UHS.N: Wells Fargo raises target price to $285 from $275 |
* Vaxcyte Inc PCVX.O: Jefferies raises target price to $146 from $129 |
* Verve Therapeutics Inc VERV.O: Canaccord Genuity raises target price to $32 from $29 |
* Verve Therapeutics Inc VERV.O: H.C. Wainwright cuts target price to $14 from $15 |
* Verve Therapeutics Inc VERV.O: RBC cuts target price to $17 from $20 |
* Viper Energy Inc VNOM.O: JP Morgan cuts target price to $43 from $45 |
* Viper Energy Inc VNOM.O: Truist Securities raises target price to $64 from $57 |
* Vitesse Energy Inc VTS.N: Alliance Global Partners cuts to neutral from buy |
* Walmart WMT.N: TD Cowen raises target price to $90 from $85 |
* Westlake Corp WLK.N: Mizuho cuts target price to $155 from $170 |
* Westlake Corp WLK.N: Wells Fargo cuts target price to $160 from $180 |
* Wynn Resorts Ltd WYNN.O: HSBC cuts target price to $99 from $127 |
* Wynn Resorts Ltd WYNN.O: Mizuho cuts target price to $118 from $125 |
* Xometry Inc XMTR.O: Citigroup raises target price to $33 from $25 |
* Xometry Inc XMTR.O: RBC raises target price to $27 from $23 |
* Xometry Inc XMTR.O: UBS raises target price to $22 from $20 |
* Xylem Inc XYL.N: TD Cowen cuts target price to $125 from $138 |
* Yum Brands YUM.N: Barclays cuts target price to $155 from $160 |
* Yum Brands YUM.N: Citigroup cuts target price to $153 from $162 |
* Yum Brands YUM.N: Deutsche Bank cuts target price to $145 from $147 |
* Yum Brands YUM.N: Morgan Stanley cuts target price to $158.00 from $160.00 |
* Zoetis Inc ZTS.N: Jefferies cuts target price to $200 from $210 |
(Compiled by Bengaluru Newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.